NEWARK, Del., April 27, 2022 (GLOBE NEWSWIRE) -- Key stakeholders are increasingly investing in vital signs monitoring devices as well as the development of innovative products. The global vital signs monitoring devices market was valued at US$ 6.8 Bn in 2022, and is expected to exhibit a CAGR of 8.4% during the forecast period (2022-2030).
Increasing adoption of vital signs monitoring devices by clinicians for the measurement of vital signs of hospitalized patients has immensely attracted market players’ attention. However, continuous focus among manufacturers on developing new vital signs monitoring devices is also expected to propel market growth during forecast period.
Moreover, growing demand for portable and low-cost devices is creating significant opportunity for global vital signs monitoring devices market players to develop and launch novel products and expand their businesses.
Request a report sample to gain comprehensive insights at
https://www.futuremarketinsights.com/reports/sample/rep-gb-410
The healthcare industry is at the front line of the coronavirus (COVID-19) pandemic. As epidemiological numbers continue to soar, the industry is running out of resources for treating the expanding patient pool. In a bid to ease off the burden, players such as Medtronic Plc. and Masimo Corporation are launching vital signs monitoring devices to treat patients remotely.
Key Takeaways of Vital Signs Monitoring Devices Market Study
- Monitors, followed by temperature measurement devices, account for a larger value share in the global vital signs monitoring devices market, owing to their increasing use in hospitals and other diagnosis centres for patient monitoring.
- Standalone vital signs monitoring devices hold a leading revenue share, owing to their availability and increasing installation rates in hospitals and other healthcare centres.
- Hospitals capture around 70% value share in the vital signs monitoring devices market, owing to high patient preference for diagnosis and treatment of different diseases in these settings.
- North America will continue to define stakeholders’ bottom lines in the global vital signs monitoring devices market during forecast period.
- Upsurge in government funding to increase the number of hospitals and improve quality of care is expected to drive the growth of the vital signs monitoring devices market in Asia.
For any Queries Related with the Report, Ask an Analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-410
New Product Development and Launch – Imperative Strategy for Market Players
Market introduction of new innovative products as per patients’ needs is majorly responsible for intense competition among players in the vital signs monitoring devices market. Several companies are focusing on launching customizable vital signs monitoring devices in order to increase their product sales and expand market share.
For example, in December 2021, Nihon Kohden Corporation launched the life scope SVM-7200 series vital sign monitors – easy-to-use, portable monitors having customizable early warning functionality to help clinicians.
What else is in the report?
Future Market Insights offer a unique perspective and actionable insights on the vital signs monitoring devices market in its latest study, presenting historical demand assessment of 2012-2021 and projections for 2022-2030, based on product (monitors, temperature measurement devices, blood pressure measurement devices, and standalone pulse oximeters), mount type (standalone and portable), end user (hospitals, clinics, ambulatory surgical centres, and home care settings), across seven key regions.
We Offer tailor-made Solutions to fit Your Requirements, Request Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-410
Explore wide-ranging Coverage of FMI's Healthcare Market Insights Landscape
In Vitro Diagnostics Market – During the forecast period, the sales of in-vitro diagnostics hold an average growth prospect with an anticipated CAGR of 3% CAGR to reach a valuation of US$ 113 Bn by 2026, from US$ 98.2 Bn in 2021.
Companion Animal Drugs Market – Expanding at a CAGR of 5%, the global companion animal drugs market is projected to increase from a valuation of US$ 36.94 Bn in 2022 to US$ 47.23 Bn by the end of 2027.
Mobile Sterile Units Market – Demand in the mobile sterile units market is expected to increase by 5.5% CAGR from 2021 to 2031. In 2021, the market stood at US$ 205.4 Mn.
Telehealth and Telemedicine Market – The telehealth and telemedicine market is projected to attain a CAGR of 24.2% during the forecast period, up from US$ 87 Bn in 2022, to reach a valuation of US$ 285 Bn by 2027.
Aromatherapy Market – The global aromatherapy market is currently valued at around US$ 5.9 Bn, and is anticipated to surge ahead at a CAGR of 8.1% to reach a market value of US$ 8.06 Bn by the end of 2026.
About Future Market Insights (FMI)
Future Market Insights (ESOMAR certified market research organization and a member of the Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favour the market growth in various segments based on Source, Application, Sales Channel and End-Use over the next 10-years.
Contact:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
Report: https://www.futuremarketinsights.com/reports/vital-signs-monitoring-devices-market
